Carrera Capital Advisors Has $3.25 Million Holdings in Colgate-Palmolive (NYSE:CL)

Carrera Capital Advisors decreased its position in Colgate-Palmolive (NYSE:CL) by 8.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,787 shares of the company’s stock after selling 3,383 shares during the quarter. Colgate-Palmolive comprises approximately 0.8% of Carrera Capital Advisors’ investment portfolio, making the stock its 23rd biggest position. Carrera Capital Advisors’ holdings in Colgate-Palmolive were worth $3,253,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Bernard Wealth Management Corp. bought a new position in Colgate-Palmolive during the fourth quarter worth about $36,000. Finally, Roxbury Financial LLC acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $43,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $91.09 on Wednesday. The stock has a market cap of $73.92 billion, a price-to-earnings ratio of 25.88, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a 50 day simple moving average of $88.73 and a 200 day simple moving average of $95.29. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CL. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday. Raymond James reissued an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.